Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Furthermore, recently identified ERK1/2-inducing mutations in MEK1 and MEK2 (MEK1/2) MAPK genes in melanoma confer resistance to emerging therapeutic MEK inhibitors, underscoring the challenges facing direct kinase inhibition in cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP509629.RApG1MCG9eYvKCcnylYdsD1Oqj2-Iajl9gWtLWOWp8ubQ130_assertion description "[Furthermore, recently identified ERK1/2-inducing mutations in MEK1 and MEK2 (MEK1/2) MAPK genes in melanoma confer resistance to emerging therapeutic MEK inhibitors, underscoring the challenges facing direct kinase inhibition in cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP509629.RApG1MCG9eYvKCcnylYdsD1Oqj2-Iajl9gWtLWOWp8ubQ130_provenance.
• NP839269.RAflh2vEZI7DWXDEOF9GT93EsdT3_DAuKv1yuNKBrn2JE130_assertion description "[Furthermore, recently identified ERK1/2-inducing mutations in MEK1 and MEK2 (MEK1/2) MAPK genes in melanoma confer resistance to emerging therapeutic MEK inhibitors, underscoring the challenges facing direct kinase inhibition in cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP839269.RAflh2vEZI7DWXDEOF9GT93EsdT3_DAuKv1yuNKBrn2JE130_provenance.
• NP662783.RA0HanNMnSbvJEm945LT-NnRS08M7FW3DkCcxy2qGUmIo130_assertion description "[Furthermore, recently identified ERK1/2-inducing mutations in MEK1 and MEK2 (MEK1/2) MAPK genes in melanoma confer resistance to emerging therapeutic MEK inhibitors, underscoring the challenges facing direct kinase inhibition in cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP662783.RA0HanNMnSbvJEm945LT-NnRS08M7FW3DkCcxy2qGUmIo130_provenance.
• NP645787.RAcONio1EXie7X1UnT1Q7RycyVBXrmJUSZIPwKKkc6dHM130_assertion description "[Furthermore, recently identified ERK1/2-inducing mutations in MEK1 and MEK2 (MEK1/2) MAPK genes in melanoma confer resistance to emerging therapeutic MEK inhibitors, underscoring the challenges facing direct kinase inhibition in cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP645787.RAcONio1EXie7X1UnT1Q7RycyVBXrmJUSZIPwKKkc6dHM130_provenance.
• assertion description "[Furthermore, recently identified ERK1/2-inducing mutations in MEK1 and MEK2 (MEK1/2) MAPK genes in melanoma confer resistance to emerging therapeutic MEK inhibitors, underscoring the challenges facing direct kinase inhibition in cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Furthermore, recently identified ERK1/2-inducing mutations in MEK1 and MEK2 (MEK1/2) MAPK genes in melanoma confer resistance to emerging therapeutic MEK inhibitors, underscoring the challenges facing direct kinase inhibition in cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Furthermore, recently identified ERK1/2-inducing mutations in MEK1 and MEK2 (MEK1/2) MAPK genes in melanoma confer resistance to emerging therapeutic MEK inhibitors, underscoring the challenges facing direct kinase inhibition in cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP708071.RAK2zTXBitfi8yEC2VK-kJoMFHpGVl0TX4_e9Hmjjrvsg130_assertion description "[Furthermore, recently identified ERK1/2-inducing mutations in MEK1 and MEK2 (MEK1/2) MAPK genes in melanoma confer resistance to emerging therapeutic MEK inhibitors, underscoring the challenges facing direct kinase inhibition in cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP708071.RAK2zTXBitfi8yEC2VK-kJoMFHpGVl0TX4_e9Hmjjrvsg130_provenance.
• NP1071114.RAWM1yld1-btgzW6AuXkH1rbfyu-R0-pc0urc9k7dlDxg130_assertion description "[Furthermore, recently identified ERK1/2-inducing mutations in MEK1 and MEK2 (MEK1/2) MAPK genes in melanoma confer resistance to emerging therapeutic MEK inhibitors, underscoring the challenges facing direct kinase inhibition in cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1071114.RAWM1yld1-btgzW6AuXkH1rbfyu-R0-pc0urc9k7dlDxg130_provenance.
• NP645860.RAnpaqVOPQYEF76zUroFJhi2Jyk46uadiQBhho9i1FFiI130_assertion description "[Furthermore, recently identified ERK1/2-inducing mutations in MEK1 and MEK2 (MEK1/2) MAPK genes in melanoma confer resistance to emerging therapeutic MEK inhibitors, underscoring the challenges facing direct kinase inhibition in cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP645860.RAnpaqVOPQYEF76zUroFJhi2Jyk46uadiQBhho9i1FFiI130_provenance.
• NP645972.RA2bLpP_aMVax1F4ePDGoDdZfRNFqdz8aNOVsfFRBDN8s130_assertion description "[Furthermore, recently identified ERK1/2-inducing mutations in MEK1 and MEK2 (MEK1/2) MAPK genes in melanoma confer resistance to emerging therapeutic MEK inhibitors, underscoring the challenges facing direct kinase inhibition in cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP645972.RA2bLpP_aMVax1F4ePDGoDdZfRNFqdz8aNOVsfFRBDN8s130_provenance.
• NP646473.RA9EKcdUwWIvm0IFPmiOt8K-c90h4CJQAdceGK1o1OC8I130_assertion description "[Furthermore, recently identified ERK1/2-inducing mutations in MEK1 and MEK2 (MEK1/2) MAPK genes in melanoma confer resistance to emerging therapeutic MEK inhibitors, underscoring the challenges facing direct kinase inhibition in cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP646473.RA9EKcdUwWIvm0IFPmiOt8K-c90h4CJQAdceGK1o1OC8I130_provenance.
• NP1071115.RAMkbTNzBO3QxqHq-69lqPKr4L_ySp199wxA40CzeEp6o130_assertion description "[Furthermore, recently identified ERK1/2-inducing mutations in MEK1 and MEK2 (MEK1/2) MAPK genes in melanoma confer resistance to emerging therapeutic MEK inhibitors, underscoring the challenges facing direct kinase inhibition in cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1071115.RAMkbTNzBO3QxqHq-69lqPKr4L_ySp199wxA40CzeEp6o130_provenance.